Systematically collected information used to understand patterns of substance use, substance use disorders, treatment needs, and drug market dynamics. This may include epidemiological data, service utilisation records, treatment outcomes, law enforcement intelligence, and public health surveillance. Data helps identify emerging trends, assess the effectiveness of prevention and treatment programmes, monitor trafficking and market activity, and guide evidence-informed policy and decision-making. Reliable data systems are essential for improving responses to substance use and ensuring that interventions are targeted, effective, and responsive to population needs.
Data
50 Años de Atención de las Adicciones
This year Centers for Youth Integration, AC (CIJ) celebrates 50 years of uninterrupted work in prevention, treatment, rehabilitation, research and addiction training.
That is why the 20th International Congress on Addictions will commemorate these 50 years of attention to drug use.
Symposium on Campus-based Interventions to Reduce Alcohol-related Harms Among College and University Students
Hear from international experts, network with colleagues working to reduce alcohol harms on Canadian campuses, and learn more about strategies and programs targeting individual students, the campus culture and surrounding communities.
Speakers to include:
Dr Jennifer Merrill, Brown University, Rhode Island, U.S.
Students’ Motivation for Change
Registration is now open and is free of charge.
Tobacco Use Among Lesbian, Gay, Bisexual and Transgender Young Adults
It is recognised that smoking and use of tobacco products among lesbian, gay, bisexual, transgender and queer (LGBTQ) young adults is higher compared to their heterosexual and cisgender peers. Although it is believed that within the LGBTQ...
Drug-related Deaths and Mortality in Europe: Update from the EMCDDA Expert Network
This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond. It draws on...
Psychostimulant Use and the Brain
Over the past decade there has been an increase in the manufacture and use of psychostimulants in countries around the world. Around two-thirds of illicit psychostimulant users are male with average age of use for methamphetamine and...
Prevalence and Risk Factors for Initiating Tobacco and Alcohol Consumption in Adolescents Living in Urban and Rural Ethiopia
Both alcohol and tobacco use is an increasing public health concern in low- or middle-income countries. Due to an annual economic growth rate of approximately 10%, Ethiopia is a target for both the alcohol and tobacco industries. Although...
Alcohol, Tobacco & Other Drugs in Australia Web Report
The consumption of alcohol, tobacco and other drugs is a major cause of preventable disease and illness in Australia. This report consolidates the most recently available information on alcohol, tobacco and other drug use in Australia, and...
Youth Substance Abuse and Co-Occurring Disorders
70%–80% of adolescents with a substance use disorder also manifest comorbid psychopathology, known also as co-occurring disorders or dual diagnosis. Co-occurring disorders are the presence of one or more comorbid psychiatric disorders in...
World Drug Report 2019
The World Drug Report aims at improving the understanding of the world drug problem and contributing towards fostering greater international cooperation for countering its impact on health, governance and security. The World Drug Report...
ASH Fact Sheet: Use of E-Cigarettes among Young People in Great Britain
This fact sheet uses the ASH smokefree GB survey of 11-18-year-olds 2013-2019, and other sources, to examine evolving youth use of e-cigarettes in Britain in the context of changes in the regulation of e-cigarettes, and use of tobacco among...